Clinical Research Directory
Browse clinical research sites, groups, and studies.
Engineering Immune Organoids to Study Pediatric Cancer
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Summary
To engineer immune organoids from pediatric patient tissues using induced-pluripotent stem cells (iPSC)
Official title: Engineering Immune Organoids to Study Pediatric Cancer (IMMUNE-ORGANOIDS)
Key Details
Gender
All
Age Range
Any - 25 Years
Study Type
INTERVENTIONAL
Enrollment
108
Start Date
2023-05-12
Completion Date
2028-05
Last Updated
2026-02-09
Healthy Volunteers
No
Interventions
Skin biopsy
Skin biopsy
Fresh tumor sample
Fresh tumor sample
Blood sample
Blood sample in heparin tubes (highly recommended), to be collected before starting treatment or as soon as hematological recovery has been reached
Healthy tissue from the tumor
Healthy tissue from the tumor site whenever possible
Spinal cerebrospinal fluid (SCF)
Spinal cerebrospinal fluid (SCF) whenever possible
Locations (2)
Gustave Roussy
Villejuif, France
Hopital Necker
Paris, Île-de-France Region, France